Literature DB >> 21725350

Hepatitis: Treatment failure in chronic hepatitis B.

Fabien Zoulim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21725350     DOI： 10.1038/nrgastro.2011.104

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

1.  Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B.

Authors:  Watcharasak Chotiyaputta; Carolyn Peterson; Fausta A Ditah; Diane Goodwin; Anna S F Lok
Journal:  J Hepatol       Date:  2010-08-20       Impact factor: 25.083

2.  Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B.

Authors:  S J Patterson; J George; S I Strasser; A U Lee; W Sievert; A J Nicoll; P V Desmond; S K Roberts; S Locarnini; S Bowden; P W Angus
Journal:  Gut       Date:  2010-10-29       Impact factor: 23.059

Review 3.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

4.  HIV-1 viral load blips are of limited clinical significance.

Authors:  Patricia K Lee; Tara L Kieffer; Robert F Siliciano; Richard E Nettles
Journal:  J Antimicrob Chemother       Date:  2006-03-13       Impact factor: 5.790

5.  Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.

Authors:  Chanunta Hongthanakorn; Watcharasak Chotiyaputta; Kelly Oberhelman; Robert J Fontana; Jorge A Marrero; Tracy Licari; Anna S F Lok
Journal:  Hepatology       Date:  2011-06       Impact factor: 17.425

6.  No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus.

Authors:  Andrea Snow-Lampart; Brandi Chappell; Maria Curtis; Yuao Zhu; Florence Myrick; James Schawalder; Kathryn Kitrinos; Evguenia S Svarovskaia; Michael D Miller; Jeff Sorbel; Jenny Heathcote; Patrick Marcellin; Katyna Borroto-Esoda
Journal:  Hepatology       Date:  2010-12-22       Impact factor: 17.425

Review 7.  Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?

Authors:  Vincent Soriano; Alan S Perelson; Fabien Zoulim
Journal:  J Antimicrob Chemother       Date:  2008-04-25       Impact factor: 5.790

Review 8.  Hepatitis B virus resistance to nucleos(t)ide analogues.

Authors:  Fabien Zoulim; Stephen Locarnini
Journal:  Gastroenterology       Date:  2009-09-06       Impact factor: 22.682

9.  Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

Authors:  Bettina Werle-Lapostolle; Scott Bowden; Stephen Locarnini; Karsten Wursthorn; Jorg Petersen; George Lau; Christian Trepo; Patrick Marcellin; Zachary Goodman; William E Delaney; Shelly Xiong; Carol L Brosgart; Shan-Shan Chen; Craig S Gibbs; Fabien Zoulim
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682

10.  Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

Authors:  Ting-Tsung Chang; Ching-Lung Lai; Seung Kew Yoon; Samuel S Lee; Henrique Sergio M Coelho; Flair Jose Carrilho; Fred Poordad; Waldemar Halota; Yves Horsmans; Naoky Tsai; Hui Zhang; Daniel J Tenney; Ricardo Tamez; Uchenna Iloeje
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425
  10 in total
  3 in total

Review 1.  Antiviral therapies and prospects for a cure of chronic hepatitis B.

Authors:  Fabien Zoulim; David Durantel
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-01       Impact factor: 6.915

2.  Efficacy of entecavir-tenofovir combination therapy for chronic hepatitis B patients with multidrug-resistant strains.

Authors:  Yun Bin Lee; Jeong-Hoon Lee; Dong Hyeon Lee; Hyeki Cho; Hongkeun Ahn; Won-Mook Choi; Young Youn Cho; Minjong Lee; Jeong-Ju Yoo; Yuri Cho; Eun Ju Cho; Su Jong Yu; Yoon Jun Kim; Jung-Hwan Yoon; Chung Yong Kim; Hyo-Suk Lee
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

3.  Assessment of Adherence to Prescribed Therapy in Patients with Chronic Hepatitis B.

Authors:  Rodrigo Martins Abreu; Camila da Silva Ferreira; Aline Siqueira Ferreira; Eduardo Remor; Paulo Dominguez Nasser; Flair José Carrilho; Suzane Kioko Ono
Journal:  Infect Dis Ther       Date:  2016-01-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.